Cyberonics Depression Study Yields Benefit In Treatment-Resistant Patients
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics will present data from its D-04 depression trial in July to determine if venous nerve stimulation (VNS) was responsible for a marked improvement in depression symptoms compared to its D-02 study